Finnrick - Ensuring a Safer and More Transparent Supply Chain
Alimo Peptide

Alimo Peptide
Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP antagonist) from Alimo Peptide between 11 Jun 2025 and 11 Aug 2025. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).

Finnrick Rating™
D
POOR
Tentative Rating
Alimo Peptide
Tirzepatide
Tested 4 Samples
Last test 11 Aug 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Alimo Peptide

Samples are tested in commercial labs

Tests Count

4

Scores

AVG6.4MIN3.8MAX10.0

Last

11 Aug 2025

First

11 Jun 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
11 Aug 2025View10.060mg
64.2mg
62.000mg-3.4%99.94%T60-2025No Label / Copper Crimp / Clear Cap Lab EPublic
5 Aug 2025View4.060mg(no batch claim)90.000mg+50.0%99.64%(no batch ID)No Label / Copper Crimp / Clear Cap Lab EPublic
29 Jun 2025View3.830mg(no batch claim)53.600mg+78.7%99.71%(no batch ID)No Label / Silver Crimp / Red Cap Lab EPublic
11 Jun 2025View7.840mg(no batch claim)39.500mg-1.3%99.80%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic